| PREVNAR 13 (pneumococcal 13-valent conjugate vaccine) / Pfizer |
| Completed | 4 | 224 | RoW | Influenza vaccination with PPV23, Influenza vaccination with PCV13 | Korea University Guro Hospital | Influenza, Human, Pneumococcal Infections | 12/12 | 01/13 | | |
CAPITA, NCT00744263: Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults |
|
|
| Completed | 4 | 84496 | Europe | VACCINE: placebo, VACCINE: 13-valent pneumococcal conjugate vaccine, 13vPnC | Pfizer | Pneumonia, Pneumococcal, Pneumococcal Infections, 13-valent Pneumococcal Vaccine | 10/13 | 10/13 | | |
| Completed | 4 | 56 | RoW | Zinc, Zinc sulfate, Sucrose, Sucrose syrup, PCV Vaccine, Prevenar 13®, PPV Vaccine, Pneumovax® | Fakultas Kedokteran Universitas Indonesia | Thalassemia, Pneumococcal Infection | 02/14 | 02/14 | | |
| Completed | 4 | 663 | RoW | Prevnar13 (manufactured by Pfizer) | Agence de Médecine Préventive, France | Pneumococcal Infections | 05/14 | 05/14 | | |
NCT02124161: Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults. |
|
|
| Completed | 4 | 882 | US | 13-valent pneumococcal conjugate vaccine, 13vPnC, Seasonal Inactivated Influenza Vaccine, SIIV, Placebo | Pfizer | PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE | 05/15 | 05/15 | | |
| Completed | 4 | 50 | Europe | 13-valent pneumococcal conjugate vaccine (PCV13), Prevenar13® | University of Oxford | Type 1 Diabetes Mellitus | 04/16 | 01/17 | | |
